Literature DB >> 21990371

Tal1 regulates osteoclast differentiation through suppression of the master regulator of cell fusion DC-STAMP.

Nadine Courtial1, Jeske J Smink, Olga N Kuvardina, Achim Leutz, Joachim R Göthert, Jörn Lausen.   

Abstract

The balance between bone-forming osteoblasts and bone-resorbing osteoclasts is crucial to bone homeostasis, an equilibrium that is disturbed in many bone diseases. The transcription factor Tal1 is involved in the establishment of hematopoietic stem cells in the embryo and is a master regulator of hematopoietic gene expression in the adult. Here, we show that Tal1 is expressed in osteoclasts and that loss of Tal1 in osteoclast progenitors leads to altered expression of >1200 genes. We found that DC-STAMP, a key regulator of osteoclast cell fusion, is a direct target gene of Tal1 and show that Tal1 represses DC-STAMP expression by counteracting the activating function of the transcription factors PU.1 and MITF. The identification of Tal1 as a factor involved in cell fusion contributes to the understanding of osteoclast-associated diseases, including osteoporosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21990371     DOI: 10.1096/fj.11-190850

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  20 in total

1.  Mitf regulates osteoclastogenesis by modulating NFATc1 activity.

Authors:  Ssu-Yi Lu; Mengtao Li; Yi-Ling Lin
Journal:  Exp Cell Res       Date:  2014-08-22       Impact factor: 3.905

2.  E proteins regulate osteoclast maturation and survival.

Authors:  Courtney L Long; William L Berry; Ying Zhao; Xiao-Hong Sun; Mary Beth Humphrey
Journal:  J Bone Miner Res       Date:  2012-12       Impact factor: 6.741

Review 3.  DC-STAMP: A Key Regulator in Osteoclast Differentiation.

Authors:  Ya-Hui Chiu; Christopher T Ritchlin
Journal:  J Cell Physiol       Date:  2016-06-14       Impact factor: 6.384

4.  D-chiro-inositol negatively regulates the formation of multinucleated osteoclasts by down-regulating NFATc1.

Authors:  Jungeun Yu; Seunga Choi; Eui-Soon Park; Bongjin Shin; Jiyeon Yu; Seoung Hoon Lee; Masamichi Takami; Jong Soon Kang; Hyungun Meong; Jaerang Rho
Journal:  J Clin Immunol       Date:  2012-06-19       Impact factor: 8.317

5.  Aging and menopause reprogram osteoclast precursors for aggressive bone resorption.

Authors:  Anaïs Marie Julie Møller; Jean-Marie Delaissé; Jacob Bastholm Olesen; Jonna Skov Madsen; Luisa Matos Canto; Troels Bechmann; Silvia Regina Rogatto; Kent Søe
Journal:  Bone Res       Date:  2020-07-01       Impact factor: 13.567

6.  Osteoclast fusion and regulation by RANKL-dependent and independent factors.

Authors:  Lianping Xing; Yan Xiu; Brendan F Boyce
Journal:  World J Orthop       Date:  2012-12-18

Review 7.  STATs and macrophage fusion.

Authors:  Takeshi Miyamoto
Journal:  JAKSTAT       Date:  2013-04-23

8.  Impact of docosahexaenoic acid on gene expression during osteoclastogenesis in vitro--a comprehensive analysis.

Authors:  Masako Akiyama; Ken-ichi Nakahama; Ikuo Morita
Journal:  Nutrients       Date:  2013-08-13       Impact factor: 5.717

9.  The T-cell oncogene Tal2 Is a Target of PU.1 and upregulated during osteoclastogenesis.

Authors:  Nadine Courtial; Christian Mücke; Stefanie Herkt; Stephan Kolodziej; Helge Hussong; Jörn Lausen
Journal:  PLoS One       Date:  2013-09-26       Impact factor: 3.240

10.  Strawberry notch homologue 2 regulates osteoclast fusion by enhancing the expression of DC-STAMP.

Authors:  Kenta Maruyama; Satoshi Uematsu; Takeshi Kondo; Osamu Takeuchi; Mikaël M Martino; Takumi Kawasaki; Shizuo Akira
Journal:  J Exp Med       Date:  2013-08-26       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.